BIO-PATH HOLDINGS INC
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
BPTH$0.21-66.8%Stored close · as of Feb 18, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Shareholders’ Equity
(in thousands)
| | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · Additional · · · · | ||||||||||||||
| · · Common Stock · · Paid in · · Accumulated · · | ||||||||||||||
| Description · Shares · Amount · Capital · Deficit · Total | ||||||||||||||
| · · · · | ||||||||||||||
| Balance at December 31, 2021 | 358 | | $1 | | $103,117 | | $(77,661) | | $25,457 | |||||
| | | | | | | | | | ||||||
| Issuance of common stock, net of fees | 40 | | — | | 1,734 | | — | | 1,734 | |||||
| Stock-based compensation | — | | — | | 851 | | — | | 851 | |||||
| Net loss | — | | — | | — | | (13,868) | | (13,868) | |||||
| | | | | | | | | |||||||
| Balance at December 31, 2022 | 398 | | $1 | | $105,702 | | $(91,529) | | $14,174 | |||||
| | | | | | | | | | | | | | | |
| | | | | | | | ||||||||
| Balance at December 31, 2022 | 398 | | $1 | | $105,702 | | $(91,529) | | $14,174 | |||||
| | | | | | | | | |||||||
| Issuance of common stock, net of fees | 175 | | — | | 491 | | — | | 491 | |||||
| Exercise of warrants, net of fees | 45 | | — | | 1,120 | | — | | 1,120 | |||||
| Stock-based compensation | — | | — | | 734 | | — | | 734 | |||||
| Net loss | — | | — | | — | | (16,078) | | (16,078) | |||||
| | | | | | | | | |||||||
| Balance at December 31, 2023 | 618 | | $1 | | $108,047 | | $(107,607) | | $441 | |||||
Bio-Path Holdings, Inc.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.